Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Seer Inc Cl A (NQ: SEER ) 2.000 +0.060 (+3.09%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Seer Inc Cl A < Previous 1 2 Next > Seer to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference August 22, 2024 From Seer, Inc. Via GlobeNewswire Seer Appoints Nicolas Roelofs to its Board of Directors August 14, 2024 From Seer, Inc. Via GlobeNewswire Seer to Participate in the Canaccord Genuity 44th Annual Growth Conference August 09, 2024 From Seer, Inc. Via GlobeNewswire Seer Reports Second Quarter 2024 Financial Results August 08, 2024 Launched STAC in Europe and additional customer papers published in leading journals From Seer, Inc. Via GlobeNewswire Seer to Report Second Quarter 2024 Financial Results on August 8, 2024 July 18, 2024 From Seer, Inc. Via GlobeNewswire Seer Proteograph™ Provides Differentiated Insights into Spaceflight Proteomic Alterations for Precision Medicine and Biomarker Discovery June 11, 2024 From Seer, Inc. Via GlobeNewswire Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ’s Early Cancer Detection Study June 02, 2024 Combined Workflow of Proteograph™ XT Assay and Thermo Scientific™ Orbitrap™ Astral™ Mass Spectrometer Robustly Identifies over 13,000 Protein Groups Across a Study of 2,840 Subjects From Seer, Inc. Via GlobeNewswire Seer Reports First Quarter 2024 Financial Results May 08, 2024 Demonstrated the power of the Proteograph Product Suite with a growing number of customer presentations and publications From Seer, Inc. Via GlobeNewswire Seer Launches New Technology Access Center in Europe to Expand Accessibility to Unbiased Proteomic Solutions May 08, 2024 From Seer, Inc. Via GlobeNewswire Seer to Report First Quarter 2024 Financial Results on May 8, 2024 April 23, 2024 From Seer, Inc. Via GlobeNewswire Seer Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Outlook February 29, 2024 Enhanced access to the Proteograph Product Suite and demonstrated its power with new customer data From Seer, Inc. Via GlobeNewswire Seer to Participate in the TD Cowen 44th Annual Health Care Conference February 21, 2024 From Seer, Inc. Via GlobeNewswire Seer Proteograph™ Enables Unprecedented Genetic Marker Mapping for Proteogenomics Studies to Advance Drug and Biomarker Discovery February 06, 2024 From Seer, Inc. Via GlobeNewswire Seer to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024 February 01, 2024 From Seer, Inc. Via GlobeNewswire Seer to Present at the J.P. Morgan 42nd Annual Health Care Conference December 21, 2023 From Seer, Inc. Via GlobeNewswire Seer to Present at the Canaccord MedTech, Diagnostics and Digital Health & Services Forum November 10, 2023 From Seer, Inc. Via GlobeNewswire Seer Wins Proteomics Solution of the Year by BioTech Breakthrough and Named #5 on Deloitte Technology Fast 500 November 08, 2023 Seer technology receives recognition for excellence in the field of proteomics From Seer, Inc. Via GlobeNewswire Seer Reports Third Quarter 2023 Financial Results November 07, 2023 Expanded access to the Proteograph™ Product Suite through the Seer Technology Access Center, new distributors and a new Center of Excellence From Seer, Inc. Via GlobeNewswire Seer Announces Addition of Panome Bio to Centers of Excellence (COE) Program November 01, 2023 Panome Bio adds deep, unbiased proteomics to their proprietary metabolomics platform to deliver innovative multi-omics services From Seer, Inc. Via GlobeNewswire Seer to Report Third Quarter 2023 Financial Results on November 7, 2023 October 19, 2023 From Seer, Inc. Via GlobeNewswire Seer to Participate in Upcoming September Investor Conferences September 08, 2023 From Seer, Inc. Via GlobeNewswire Seer Reports Second Quarter 2023 Financial Results August 08, 2023 Launched Proteograph XT Assay Kit, enabling rapid proteomics and large-scale studies From Seer, Inc. Via GlobeNewswire Seer to Present at the Canaccord Genuity 43rd Annual Growth Conference July 27, 2023 From Seer, Inc. Via GlobeNewswire Seer to Report Second Quarter 2023 Financial Results on August 8, 2023 July 13, 2023 From Seer, Inc. Via GlobeNewswire Seer Collaborates to Make Scalable, Unbiased Proteomics Accessible to More Researchers via new Seer Technology Access Center June 07, 2023 Expanded collaboration with Thermo Fisher Scientific combines the new Seer Proteograph™ XT Assay Kit with the new Thermo Scientific™ Orbitrap™ Astral™ Mass Spectrometer to empower the scientific... From Seer, Inc. Via GlobeNewswire Seer Launches the Proteograph XT Assay Kit: Allowing Labs to Easily Expand Their View of the Proteome and Scale Their Studies June 01, 2023 Seer’s Proteograph XT pushes the boundaries of biological discovery by enabling rapid proteomics across a range of sample types and species with unprecedented resolution and scale From Seer, Inc. Via GlobeNewswire Seer Reports First Quarter 2023 Financial Results May 09, 2023 From Seer, Inc. Via GlobeNewswire Seer to Report First Quarter 2023 Financial Results on May 9, 2023 April 20, 2023 From Seer, Inc. Via GlobeNewswire Seer’s Proteograph™ Product Suite identifies undiscovered links between protein variants and lung cancer progression March 29, 2023 Peptide-level insights from deep, unbiased proteomics enable protein variant analysis of patient samples, revealing potential non-small cell lung cancer biomarkers From Seer, Inc. Via GlobeNewswire Seer Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Full Year 2023 Outlook March 02, 2023 Grew revenue 134% and increased instruments shipped 129% year over year From Seer, Inc. Via GlobeNewswire < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.